Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | GALR3 | O60755 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8165016 | 0.83 | TSHR (0.42) | TSHRHSD17B10TDP1ALDH1A1CHRM2 | |
| SCHEMBL5772368 | 0.81 | TSHR (0.40) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| SCHEMBL7591554 | 0.77 | ALDH1A1 (0.38) | TSHRTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL6921613 | 0.74 | ALDH1A1 (0.35) | TSHRALDH1A1 | |
| SCHEMBL7590532 | 0.73 | TSHR (0.33) | TSHR | |
| SCHEMBL3503019 | 0.72 | — | — | |
| SCHEMBL13454198 | 0.72 | TSHR (0.46) | TSHRHSD17B10TDP1ALDH1A1CHRM2 | |
| SCHEMBL13419032 | 0.72 | TSHR (0.46) | TSHRHSD17B10TDP1ALDH1A1CHRM2 | |
| SCHEMBL19333598 | 0.72 | TSHR (0.46) | TSHRHSD17B10TDP1ALDH1A1CHRM2 | |
| SCHEMBL992095 | 0.72 | TSHR (0.46) | TSHRHSD17B10TDP1ALDH1A1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042929-A1 | COMPOSITION FOR ELECTROCHEMICAL DEVICE FUNCTIONAL LAYER, FUNCTIONAL LAYER FOR ELECTROCHEMICAL DEVICE, LAMINATE FOR ELECTROCHEMICAL DEVICE, AND ELECTROCHEMICAL DEVICE | ZEON CORPORATION (JP) | 2026-02-12 | — | — | US | disclosed |
| EP-4583293-A1 | COMPOSITION FOR ELECTROCHEMICAL ELEMENT FUNCTIONAL LAYER, FUNCTIONAL LAYER FOR ELECTROCHEMICAL ELEMENT, LAMINATE FOR ELECTROCHEMICAL ELEMENT, AND ELECTROCHEMICAL ELEMENT | Zeon Corporation (JP) | 2025-07-09 | — | — | EP | disclosed |
| US-12290611-B2 | Cell or tissue embedding device | JAPAN VAM & POVAL CO., LTD. (JP) | 2025-05-06 | — | — | US | disclosed |
| US-20250118863-A1 | COMPOSITION CONTAINING INORGANIC-ORGANIC HYBRID COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-04-10 | — | — | US | disclosed |
| CN-119585934-A | Composition for functional layer of electrochemical element, functional layer for electrochemical element, laminate for electrochemical element, and electrochemical element | 日本瑞翁株式会社 | 2025-03-07 | — | — | CN | disclosed |
| EP-4458900-A1 | COMPOSITION CONTAINING INORGANIC/ORGANIC HYBRID COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-11-06 | — | — | EP | disclosed |
| EP-3586824-B1 | CELL- OR TISSUE-EMBEDDING DEVICE | JAPAN VAM & POVAL CO LTD (JP) | 2024-09-04 | — | — | EP | disclosed |
| CN-118265752-A | Composition containing inorganic/organic hybrid compound | 信越化学工业株式会社 | 2024-06-28 | — | — | CN | disclosed |
| US-20240100227-A1 | IMPLANTATION DEVICE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-03-28 | — | — | US | disclosed |
| US-20240091404-A1 | GELATIN-CONTAINING DEVICE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-03-21 | — | — | US | disclosed |
| EP-4101479-A1 | ANGIOGENESIS DEVICE | Shin-Etsu Chemical Co., Ltd. (JP) | 2022-12-14 | — | — | EP | disclosed |
| EP-3059266-B1 | METHOD OF PRODUCING POLYVINYL ALCOHOL RESIN, AND POLYVINYL ALCOHOL RESIN OBTAINED THEREBY | JAPAN VAM & POVAL CO LTD (JP) | 2020-10-21 | — | — | EP | disclosed |
| US-20200231960-A1 | CELL OR TISSUE EMBEDDING DEVICE | NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY (JP) | 2020-07-23 | — | — | US | disclosed |
| EP-2799474-B1 | MANUFACTURING PROCESS FOR SHAPED ARTICLE MADE OF POROUS HYDROGEL | KURARAY CO (JP) | 2020-05-20 | — | — | EP | disclosed |
| US-9868840-B2 | Shaped article made of porous hydrogel, manufacturing process therefor and use thereof | KURARAY CO., LTD. (JP) | 2018-01-16 | — | — | US | disclosed |
| US-20160271988-A1 | METHOD FOR PRODUCING POLYVINYL ALCOHOL RESIN, AND POLYVINYL ALCOHOL RESIN OBTAINED BY THE METHOD | JAPAN VAM & POVAL CO., LTD. (JP) | 2016-09-22 | — | — | US | disclosed |
| EP-3059266-A1 | METHOD OF PRODUCING POLYVINYL ALCOHOL RESIN, AND POLYVINYL ALCOHOL RESIN OBTAINED THEREBY | Japan Vam & Poval Co., Ltd. (JP) | 2016-08-24 | — | — | EP | disclosed |
| US-20140353248-A1 | SHAPED ARTICLE MADE OF POROUS HYDROGEL, MANUFACTURING PROCESS THEREFOR AND USE THEREOF | KURARAY CO., LTD. (JP) | 2014-12-04 | — | — | US | disclosed |
| EP-2799474-A1 | POROUS WATER-CONTAINING GEL MOLDED ARTICLE, METHOD FOR PRODUCING SAME, AND USE OF SAME | Kuraray Co., Ltd. (JP) | 2014-11-05 | — | — | EP | disclosed |
| EP-2562173-A1 | 2-methyl-3-(3,4.methylenedioxyphenyl) propanal, and method for production thereof | Ube Industries, Ltd. (JP) | 2013-02-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042929-A1 | COMPOSITION FOR ELECTROCHEMICAL DEVICE FUNCTIONAL LAYER, FUNCTIONAL LAYER FOR ELECTROCHEMICAL DEVICE, LAMINATE FOR ELECTROCHEMICAL DEVICE, AND ELECTROCHEMICAL DEVICE | GRIN1, L1CAM, ACP1 | TSHR 3802/4885HSD17B10 3497/4885TDP1 2674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.